Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. The global biobanking market is poised to grow by US$ 18.0 billion from 2022 to 2028, registering a CAGR of 4.5% during the forecast period, according to StrategyHelix. The report is an invaluable resource…
According to a report by StrategyHelix, the global 3d bioprinting market is set to increase by US$ 1,538.1 million during 2022-2028, growing at a CAGR of 17.3% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the 3d bioprinting market to help drive informed decision…
According to a report by StrategyHelix, the global microbiological culture market is set to increase by US$ 560.7 million during 2022-2028, growing at a CAGR of 4.2% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the microbiological culture market to help drive informed decision…
According to a report by StrategyHelix, the global environmental remediation market is set to increase by US$ 56.1 billion during 2022-2028, growing at a CAGR of 7% during the forecast period. The report is an invaluable resource for companies and…
According to a report by StrategyHelix, the global high content screening market is set to increase by US$ 839.4 million during 2022-2028, growing at a CAGR of 9.2% during the forecast period. The report is an invaluable resource for companies…
A study by StrategyHelix indicates that the global biological therapies for cancer market is expected to increase by US$ 50.0 billion from 2022 to 2028, garnering a CAGR of 8.2% during the forecast period. The report is an invaluable resource…
The global cell separation market is poised to grow by US$ 2.7 billion during 2022-2028, progressing at a CAGR of 7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies…
The rapid pathogen detection market in USA is set to increase by US$ 178.3 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 6.8% during the forecast period. The report is an invaluable resource for companies…
According to StrategyHelix, the global bioinformatics market is expected to increase by US$ 9.9 billion during 2022-2028, expanding at a CAGR of 8.1% during the forecast period. The report is an invaluable resource for companies and organizations active in this…
The global drug discovery market is poised to grow by US$ 44.3 billion from 2022 to 2028, registering a CAGR of 8.7% during the forecast period, according to StrategyHelix. The report is an invaluable resource for companies and organizations active…
Copyright © 2022 StrategyHelix Inc. All Rights Reserved.